SUMMARY We determined the underlying aetiology of blindness for the registered blind population of the Province of Newfoundland and Labrador. In both 1981 and 1984 single-gene disorders accounted for 30% of total blindness and congenital defects for another 10-11%. Genetically determined conditions, diabetes, and senile macular degeneration (SMD) were the three leading causes of registration in each year, 1980-4. We calculated mean ages of registration and mean ages of death over the last four years for five major aetiological groups. Patients with genetic conditions were registered at a much younger age and had a correspondingly longer duration of blindness (21 years as compared with 5 years for either diabetes or SMD). Total 'person-years of blindness' was then calculated from the product of this duration of blindness and the total numbers registered in each group. This index shows that the overall individual and population impact of monogenic blindness is overwhelmingly greater than that of other causes (6849 person-years compared with 270 for diabetes and 430 for SMD). In view of this frequency and duration of monogenic blindness, and also of the substantial hereditary liability to relatively common causes of blindness such as glaucoma, diabetic retinopathy, and high myopia, we suggest that more attention needs to be paid to elucidating the genetic contribution to blindness.
There is a growing awareness of the importance of genetic disease as a cause of blindness. For example, a recent paper from Saudi Arabia' reported a changing pattern of aetiology, so that fully 84% of childhood blindness in that country is now caused by hereditary conditions.
Three years ago we reported on the causes of registered blindness in Newfoundland at the end of 1981.2 Our aim was to determine as accurately as possible the underlying aetiology of blindness in each case, based on a review of the files of all persons registered with the Canadian National Institute of the Blind (CNIB) and examination of as many as possible of those cases for which the reported cause of registration was ambiguous. Single-gene disorders accounted for at least 30% of all registered blindness.
We have now brought this review of records up to date, tabulating the new registrations for the past three years-. We present here analyses comparing 1981 and 1984. We are also interested in the relative burden to the population of different causes of blindness, and therefore determined 'person-years of Correspondence to Jane S Green, Community Medicine Health Sciences Centre, St John's, Newfoundland, Canada AIB 3V6. blindness' for the different categories as an index of the personal and population impact of each.
Patients and methods

The Canadian Province of Newfoundland and
Labrador has a total population of approximately 580 000, the majority of whom live in relatively isolated, scattered coastal communities. The legal responsibility for the registration of blindness rests with the CNIB. Registration is not obligatory at present. The criteria for registration, only one of which need be met, are (a) corrected visual acuity of 6/60 or worse in the better eye, and (b) a total visual field of less than 100 from fixation using a white target 10 mm in diameter at a distance of 1 m. Table 2 shows the registrations in each of the past five years. Except in 1983, when few diabetics were registered, senile macular degeneration, genetic conditions, and diabetic retinopathy were consistently the top three causes of registration.
The mean age at registration for the new registrants of the past five years was similar to that of the total registrations in each of the five major aetiological groups (Table 3 ). The mean ages of registration of (Table 4 ). In the total registered blind population the 'person-years of blindness' attributable to diabetes were 270, to SMD 430, and to genetic diseases 6489 (Table 5 ).
Discussion
In analysing the records of all the registered blind persons in the Province our first goal was to determine as accurately as possible the underlying aetiology of the blindness. As has previously been discussed, in 15% of cases either the recorded cause of blindness or the aetiology code was found to be incorrect.2 However, by undertaking this study in a geographic area with a relatively small and stable population we could establish family histories relatively easily and frequently examine patients with ambiguous records to establish diagnoses.
The high frequency of genetic blindness in Newfoundland is not a reflection of ascertainment due to our research interests. Rather than a recent increase in the proportion of monogenic blindness we are demonstrating a continued high prevalence. Singlegene disorders accounted for 30% of total blindness in our initial study in It may be asked whether the high proportion of genetically determined blindness in Newfoundland is explained by the Province's population genetic structure. The population derives primarily by natural increase from settlers who arrived before 1835, drawn from highly circumscribed areas of south-western England and southern Ireland. Hundreds of small communities have grown up around Newfoundland's many natural harbours. At present about 50% of the population of the Province reside in communities of fewer than 2500 inhabitants, and 41% reside in communities of fewer than 1000. These small subpopulations remain genetically isolated (Bear JC, Nemec TF, Kennedy JC, et al., unpublished data). The low levels of migration into these communities and of genetic exchange between them contrast with observations from numerous studies of European isolates of comparable size where there has been increasing genetic exchange in this century. Thus frequencies of specific recessive disorders may be increased owing to inbreeding. Because closely consanguineous unions tend to be avoided, the matings are usually between distant relatives, and the frequency of a recessive disorder is reasonably ascribed to founder effect (the chance presence of an allele in relatively few original settlers of a genetically isolated population). Several instances of locally raised frequencies of autosomal dominant and X-linked ocular disorders, such as von Hippel-Lindau disease and ocular albinism, have also been described, again reasonably attributed to founder effect. Conversely, just as some deleterious alleles are found in unusually high frequency, it is to be expected that some will be infrequent or absent, and indeed no examples of Best's macular dystrophy or of choroideraemia have been identified.
It must be emphasised that a high proportion of blindness due to hereditary disease is also indicated in studies elsewhere. In a county in Norway 29*6% of blind people (vision 6/60 or less) had hereditary or probably hereditary diseases.3 Genetically determined conditions accounted for 77% of childhood blindness in Lebanon,4 79% in Cyprus (of which half were autosomal recessive),' and 84% in Saudi Arabia as already noted.' We have previously shown that the prevalence of genetic eye disease in Newfoundland was underestimated because of errors and ambiguities in coding at the time of registration of blindness.2 This underestimation could also apply to other studies where it was not possible to review all files in detail or examine as many of the patients when there was ambiguity in the coding.
Persons with monogenic blindness, as a group, are registered much younger than other blind persons, and consequently have a much longer duration of blindness. Although the mean years of blindness calculated for the group of 22 who died in 1981-4 was 21 years, higher than for other groups, this none the less greatly underestimates the usual duration of monogenic blindness. The mean age of registration for the most recent registrants in the genetic group is 25 years (Table 3) , not 46 years as in the small group who died recently. The mean years of blindness of the genetic group as a whole may therefore be expected to be around 42 years rather than 21 years and attributable 'person-years of blindness' about 13 000. Not only are monogenic conditions the leading cause of blindness, but also in 'person-years of blindness', the overall individual and population impact of monogenic blindness is overwhelmingly greater than that of other forms of blindness.
The mean duration of blindness attributed to SMD and diabetes was Regardless of the exact proportion of monogenic blindness in a particular country, the extra 'personyears of blindness' are relevant in all countries in which infectious and nutritional causes of blindness are adequately controlled. Moreover, the total genetic contribution to blindness extends well beyond the category of monogenic blinding disorders. Diabetes and glaucoma each show familial aggregation, and the genetic component in the liability to each is substantial. High myopia frequently seems strikingly familial.
While it remains of great importance to provide support through low-vision services, itinerant teachers for the visually impaired, and employment counselling, much more attention should be paid to elucidating the genetic component of blindness. This includes accurate diagnosis to provide specific recurrence risks for genetic counselling, clarification of the natural history and prognosis of individual disorders to provide specific advice for affected persons, and genetic linkage studies, to allow carrier detection and presymptomatic identification of affected individuals. 
